About Invati
Invati is a company based in Kolkata (India) founded in 2016 by Mukeshh Agarwal.. Invati has raised $5.43 million across 1 funding round from investors including Himadri Chemicals and Industries. The company has 34 employees as of February 19, 2025. Invati operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Kolkata, India
- Employees 34 as on 19 Feb, 2025
- Founders Mukeshh Agarwal
-
Sectors
TechnologyAgriculture Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Invati Creations Private Limited
- Date of Incorporation 14 Sep, 2016
- Jurisdiction Kolkata, West Bengal, India
-
Annual Revenue
$638.52 K (USD)14312.35as on Mar 31, 2024
-
Net Profit
$163.6 K (USD)18696.72as on Mar 31, 2024
-
EBITDA
$247.57 K (USD)7606.53as on Mar 31, 2024
-
Total Equity Funding
$5.43 M (USD)
in 1 rounds
-
Latest Funding Round
$5.43 M (USD), Series A
Mar 21, 2024
- Investors
-
Employee Count
34
as on Feb 19, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Invati
Invati has successfully raised a total of $5.43M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.43 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $5.4M
-
First Round
First Round
(21 Mar 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series A - Invati | Valuation | Himadri Chemicals and Industries |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Invati
Invati has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Himadri Chemicals and Industries. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufactures coal tar and basic industrial chemicals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Invati
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Invati
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Invati Comparisons
Competitors of Invati
Invati operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Invati
When was Invati founded?
Invati was founded in 2016 and raised its 1st funding round 8 years after it was founded.
Where is Invati located?
Invati is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.
Who is the current CEO of Invati?
Mukeshh Agarwal is the current CEO of Invati. They have also founded this company.
Is Invati a funded company?
Invati is a funded company, having raised a total of $5.43M across 1 funding round to date. The company's 1st funding round was a Series A of $5.43M, raised on Mar 21, 2024.
How many employees does Invati have?
As of Feb 19, 2025, the latest employee count at Invati is 34.
What is the annual revenue of Invati?
Annual revenue of Invati is $638.52K as on Mar 31, 2024.
What does Invati do?
Invati was founded in 2016 in Kolkata, India, with a focus on nanotechnology applications across agriculture, animal care, poultry, and pharmaceuticals. Mineral nutrition solutions for chickens are provided, alongside research and development of nano-based anticancer drug molecules. Pharmacy products and food additives are also developed to support these sectors. Operations emphasize innovation in nano-formulations for enhanced efficacy in targeted applications.
Who are the top competitors of Invati?
Invati's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Invati's investors?
Invati has 1 investor. Key investors include Himadri Chemicals and Industries.